Ichiro Nakashima

Sendai, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 217 publications

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: July 13, 2026

Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study.

Headache prevalence and types in multiple sclerosis and related neuroimmunological diseases: A multicenter study.

Journal: Cephalalgia : an international journal of headache

Published: March 26, 2026

Febrile infection-related epilepsy syndrome (FIRES) with the claustrum sign in a 55-year-old woman: a case report

Febrile infection-related epilepsy syndrome (FIRES) with the claustrum sign in a 55-year-old woman: a case report

Journal: Rinsho shinkeigaku = Clinical neurology

Published: March 11, 2026

Outcomes and disease activity during and after pregnancy in Asian women with MOGAD.

Outcomes and disease activity during and after pregnancy in Asian women with MOGAD.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 26, 2026

Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).

Long-term effectiveness and safety of satralizumab for neuromyelitis optica spectrum disorder in a real-world clinical setting in Japan: A 2.5-year final analysis of a multicenter medical chart review (The SAkuraBeyond Study).

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: February 24, 2026

Differences in the Neural Substrate for Physical and Mental Quality of Life in Patients With Multiple Sclerosis.

Differences in the Neural Substrate for Physical and Mental Quality of Life in Patients With Multiple Sclerosis.

Journal: Brain and behavior

Published: November 22, 2025

DCIR-mediated inhibitory regulation of TLR7-MyD88 axis prevents autoimmune neuroinflammation.

DCIR-mediated inhibitory regulation of TLR7-MyD88 axis prevents autoimmune neuroinflammation.

Journal: iScience

Published: October 24, 2025

Characterizing spinal cord atrophy in multiple sclerosis patients without disease activity or brain atrophy progression.

Characterizing spinal cord atrophy in multiple sclerosis patients without disease activity or brain atrophy progression.

Journal: Multiple sclerosis and related disorders

Published: September 11, 2025

Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance.

Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance.

Journal: Neurology and therapy

Published: April 18, 2025

CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated Disease.

CD4-Positive T-Cell Responses to MOG Peptides in MOG Antibody-Associated Disease.

Journal: International journal of molecular sciences

Published: January 31, 2025

Venglustat in GM2 gangliosidoses and related disorders: Results of the AMETHIST randomized controlled and basket trials.

Venglustat in GM2 gangliosidoses and related disorders: Results of the AMETHIST randomized controlled and basket trials.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics

Published: December 23, 2024

Employment status of multiple sclerosis patients in Japan.

Employment status of multiple sclerosis patients in Japan.

Journal: Journal of medical economics

Published: November 08, 2024

Showing 1-12 of 217

Last Updated: 09/26/2026